Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.

Pluri Inc Is A Biotechnology Company Engaged In The Research, Development, And Manufacturing Of Cell-Based Products, As Well As The Commercialization Of Cell Therapeutics And Related Technologies Aimed At Delivering Solutions Across A Range Of Industries, Including Regenerative Medicine, Immunotherapy, Food Tech, Cdmo, And Agtech. The Company Uses Its 3d Cell Expansion Technology Platform To Develop Placenta-Based Cell Therapy Product Candidates (Plx-Pad And Plx-R18) For The Treatment Of Inflammatory, Muscle Injuries, And Hematologic Conditions. In Addition, It Offers Cdmo Services Through Pluricdmo, Has Launched A Novel Immunotherapy Platform, And Is Engaged In Developing Cultivated, Cell-Cultured Coffee And Meat.